COLESTID Drug Patent Profile

✉ Email this page to a colleague

When do Colestid patents expire, and what generic alternatives are available?

Colestid is a drug marketed by Pfizer and is included in two NDAs.

The generic ingredient in COLESTID is colestipol hydrochloride. There are two drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the colestipol hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Colestid

A generic version of COLESTID was approved as colestipol hydrochloride by IMPAX LABS on May 2^nd, 2006.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for COLESTID?
What are the global sales for COLESTID?
What is Average Wholesale Price for COLESTID?

Summary for COLESTID

US Patents:	0
Applicants:	1
NDAs:	2
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	19
Clinical Trials:	1
Patent Applications:	332
Drug Prices:	Drug price information for COLESTID
What excipients (inactive ingredients) are in COLESTID?	COLESTID excipients list
DailyMed Link:	COLESTID at DailyMed

Drug patent expirations by year for COLESTID

Recent Clinical Trials for COLESTID

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
National Heart, Lung, and Blood Institute (NHLBI)	Phase 3
University of Washington	Phase 3

See all COLESTID clinical trials

Pharmacology for COLESTID

Drug Class	Bile Acid Sequestrant
Mechanism of Action	Bile-acid Binding Activity

US Patents and Regulatory Information for COLESTID

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pfizer	COLESTID	colestipol hydrochloride	GRANULE;ORAL	017563-003	Sep 22, 1995	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pfizer	COLESTID	colestipol hydrochloride	GRANULE;ORAL	017563-004	Sep 22, 1995	AB	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pfizer	COLESTID	colestipol hydrochloride	TABLET;ORAL	020222-001	Jul 19, 1994	AB	RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for COLESTID

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer	COLESTID	colestipol hydrochloride	TABLET;ORAL	020222-001	Jul 19, 1994	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for COLESTID

See the table below for patents covering COLESTID around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Finland	106843		⤷ Sign Up
Hungary	222242	Kolesztipol-hidroklorid tabletta és eljárás annak előállítására (COLESTIPOL HYDROCHLORIDE AND PROCESS FOR PRODUCTION OF IT)	⤷ Sign Up
Norway	940008		⤷ Sign Up
Russian Federation	2108090	TABLET CONTAINING CHOLESTEROL HYDROCHLORIDE AND METHOD FOR ITS PRODUCTION	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for COLESTID

Recent Clinical Trials for COLESTID

Pharmacology for COLESTID

Make Better Decisions: Try a trial or see plans & pricing